Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Fresh tissue biopsy
OTHER
2 trials
Sponsors
Washington University School of Medicine
, University of Arkansas
Conditions
Cancer of Pancreas
Cancer of the Pancreas
Head and Neck Cancer
Lung Cancer
Pancreas Cancer
Pancreatic Cancer
Phase 1
Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Terminated
NCT02352831
Washington University School of Medicine
Cancer of Pancreas, Cancer of the Pancreas, Pancreas Cancer +1
Start: 2015-08-31
End: 2018-10-19
Updated: 2019-08-28
Unknown Phase
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
Active, not recruiting
NCT02597738
University of Arkansas
Head and Neck Cancer, Lung Cancer
Start: 2016-01-01
End: 2028-12-01
Target: 330
Updated: 2026-05-29
Related Papers
A phase I/II study combining tosedostat with capecitabine in patients with metastatic pancreatic ductal adenocarcinoma (PDAC).
Journal of Clinical Oncology
2017-02-01
8 citations
A phase I/II study combining tosedostat with capecitabine in patients with metastatic pancreatic adenocarcinoma.
Journal of Clinical Oncology
2016-02-01